Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
21
Frequently Asked Questions
What is Market Cap of Immix Biopharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Immix Biopharma Inc market cap is $63.15M.
What is the 52-week high for Immix Biopharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Immix Biopharma Inc 52 week high is $3.20 as of September 06, 2025.
What is the 52-week low for Immix Biopharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Immix Biopharma Inc 52 week low is $1.26 as of September 06, 2025.
What is Immix Biopharma Inc stock price today?
Immix Biopharma Inc stock price today is $2.15.
What was Immix Biopharma Inc stock price yesterday?
Immix Biopharma Inc stock price yesterday was $2.19.
What is the PE ratio of Immix Biopharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Immix Biopharma Inc’s P/E ratio is -2.77.
What is the Price-to-Book ratio of Immix Biopharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Immix Biopharma Inc P/B ratio is 13.3700.
What is the 50-day moving average of Immix Biopharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Immix Biopharma Inc 50-day moving average is $2.48.
